The DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index.
Liver X receptor-dependent inhibition of microglial nitric oxide synthase 2
Open accessAbstract
BACKGROUND: The nuclear receptor liver X receptor (LXR) exerts transcriptional control over lipid metabolism and inflammatory response in cells of the myeloid lineage, suggesting that LXR may be a potential target in a number of chronic neuroinflammatory and neurodegenerative diseases where persistent microglial activation has been implicated in the pathogenesis. METHODS: The effect of LXR activation on microglia and central nervous system (CNS) inflammation was studied using a synthetic LXR agonist in cultured microglia, a microglial cell line and experimental allergic encephalomyelitis (EAE), an animal model of CNS inflammation. RESULTS: LXR activation inhibited nitric oxide synthase 2, inducible (Nos2) expression and nitric oxide production in lipopolysaccharide (LPS)-stimulated microglia. Inhibition of microglial activation in response to interferon-γ was less reliable. In LPS-stimulated cells, LXR activation did not inhibit nuclear translocation of NF-kappaB1 p50. Instead, LXR-dependent Nos2 repression was associated with inhibition of histone 4 acetylation and inhibition of NF-kappaB1 p50 binding at the Nos2 promoter. Histone acetylation and NF-kappaB1 p50 binding were mechanistically linked, and histone deacetylase (HDAC) activity appeared to be important for LXR-dependent transcriptional repression of Nos2. Analysis of CNS gene expression in animals undergoing EAE showed that the expressions of Lxr and LXR-dependent genes were downregulated during CNS inflammation. Nevertheless, administration of LXR agonist GW3965 during the effector phase of EAE delayed the onset of clinical disease and reversed the diminished expression of LXR-dependent reverse cholesterol transport genes. However, the CNS expressions of Nos2 and other inflammatory genes were not significantly inhibited by LXR activation in EAE, and clinical disease severity was comparable to vehicle controls at later time points in LXR agonist treated animals. CONCLUSIONS: LXR can be targeted to modulate microglial activation. LXR-dependent repression of inflammatory genes may be stimulus-dependent and impaired by HDAC inhibition. Endogenous LXR activity does not appear to modulate CNS inflammation, but LXR activity can be partially restored in the CNS by administration of exogenous LXR agonist with an impact on clinical disease severity at early, but not late, time points in EAE.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These observations agree with known anti-inflammatory and Aβ-clearing effects of LXRα/β agonists in AD models [40–42] as well as the role of Cebpα in regulating PU.1 which maintains microglial quiescence [43].”
From Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer’s disease (2018) · cites this paper as [40]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Agonists of LXRα/β, predicted to specifically promote anti-inflammatory DAM gene expression in our network analysis, have anti-inflammatory and protective effects in AD models [40, 41].”
From Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer’s disease (2018) · cites this paper as [40]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860 · cited 1×
“Relative quantitation of mRNA was performed using the comparative threshold (delta delta CT) method [17] using Actb as endogenous control.”
MethodMicroglia-mediated neurotoxicity: uncovering the molecular mechanisms
Block, M. L., Zecca, L., & Hong, J.-S. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2038 · Cited by 4,110 · cited 2×
“Discussion Persistent microglial activation has been implicated in the pathogenesis of a number of neuroinflammatory and neurodegenerative disorders [2].”
BackgroundMutation of the mouse klotho gene leads to a syndrome resembling ageing
Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837
An oxysterol signalling pathway mediated by the nuclear receptor LXRα
Janowski, B. A., Willy, P. J., Devi, T. R., Falck, J. R., & Mangelsdorf, D. J. (1996) · Nature · doi:10.1038/383728a0 · Cited by 1,591 · cited 1×
“The liver X receptor (LXR) is an oxysterol-activated nuclear receptor [6].”
BackgroundA SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-γ
Pascual, G., Fong, A. L., Ogawa, S., Gamliel, A., Li, A. C., Perissi, V., Rose, D. W., Willson, T. M., Rosenfeld, M. G., & Glass, C. K. (2005) · Nature · doi:10.1038/nature03988 · Cited by 1,254 · cited 1×
“Whereas genes involved in reverse cholesterol transport are coordinately regulated by LXR transcriptional activation involving exchange of NCoR for NCoA, the antiinflammatory effects of LXR are under SUMOylation-dependent transcriptional repression [35].”
BackgroundReciprocal regulation of inflammation and lipid metabolism by liver X receptors
Joseph, S. B., Castrillo, A., Laffitte, B. A., Mangelsdorf, D. J., & Tontonoz, P. (2003) · Nature Medicine · doi:10.1038/nm820 · Cited by 1,158 · cited 3×
“In cells of the myeloid lineage, LXR has also been shown to control inflammatory responses by transcriptional repression of a number of genes including Nos2, Cox2 and Il6 [10].”
BackgroundInfluentialExacerbations of multiple sclerosis in patients treated with gamma interferon
Panitch, H., Haley, A., Hirsch, R., & Johnson, K. (1987) · The Lancet · doi:10.1016/s0140-6736(87)92863-7 · Cited by 1,071 · cited 1×
“Stimulus-specific differences in LXR-dependent inhibition are likely to be important in neuroinflammatory diseases such as multiple sclerosis, where both Toll-like receptor and interferon-γ signaling have been reported [26-29].”
BackgroundLowenstein, C. J., Alley, E. W., Raval, P., Snowman, A. M., Snyder, S. H., Russell, S. W., & Murphy, W. J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.20.9730 · Cited by 1,064 · cited 1×
“We detected peak of LPSinduced NF-kappaB1 p50 binding at −159 to −15 bases upstream of the Nos2 transcription start site, which corresponds to the previously reported proximal enhancer cluster on the Nos2 promoter [31].”
BackgroundControl of cellular cholesterol efflux by the nuclear oxysterol receptor LXRα
Venkateswaran, A., Laffitte, B. A., Joseph, S. B., Mak, P. A., Wilpitz, D. C., Edwards, P. A., & Tontonoz, P. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.200367697 · Cited by 1,005 · cited 1×
“LXR is known to control the expression of genes involved in reverse cholesterol transport such as Abca1, Abcg1, Apoa1, Apoe and Cyp7a1 [8,9].”
BackgroundInflammation and Lipid Signaling in the Etiology of Insulin Resistance
Glass, C. K., & Olefsky, J. M. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.04.001 · Cited by 935 · cited 1×
“Thus, LXR is one among a number of biological signal pathways that link lipid metabolism and inflammation [11].”
Background
Cited by
Rangaraju, S., Dammer, E. B., Raza, S. A., Rathakrishnan, P., Xiao, H., Gao, T., Duong, D. M., Pennington, M. W., Lah, J. J., Seyfried, N. T., et al. (2018) · Molecular Neurodegeneration · doi:10.1186/s13024-018-0254-8 · Cited by 430
Shao, F., Wang, X., Wu, H., Wu, Q., & Zhang, J. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.825086 · Cited by 250
Transcriptional control of microglia phenotypes in health and disease
Holtman, I. R., Skola, D., & Glass, C. K. (2017) · Journal of Clinical Investigation · doi:10.1172/jci90604 · Cited by 218
Liver X Receptors: Regulators of Cholesterol Metabolism, Inflammation, Autoimmunity, and Cancer
Bilotta, M. T., Petillo, S., Santoni, A., & Cippitelli, M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.584303 · Cited by 171
Qiu, L., Ji, M., Zhang, H., Yang, J., Sun, X.-R., Tang, H., Wang, J., Liu, W., & Yang, J.-J. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2015.08.002 · Cited by 132
“Nicotinamide adenine dinucleotide phosphate (NADPH) oxidase is an important source of the production of ROS in phagocytes including microglia (Sorce and Krause, 2009).”
Background
Metadata
- Authors
- Secor McVoy, J. R., Oughli, H. A., & Oh, U.
- Affiliations
- Virginia Commonwealth University (US)
- Corresponding author
- Oh, Unsong
- Venue
- Journal of Neuroinflammation
- Published
- 2015-02-10
- Volume
- 12
- Issue
- 1
- Pages
- 27-27
- ISSN
- 1742-2094 (ISSN-L)
- PMC
- PMC4332930
- OpenAlex
- W2169725287
- Cited by
- 34
- References
- 43
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 4 · 2023: 2 · 2022: 2 · 2021: 3 · 2020: 5 · 2019: 5 · 2018: 1 · 2017: 3 · 2016: 3 · 2015: 2
- FWCI
- 1.60
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Journal of Neuroinflammation (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- VCU Scholars Compass (Virginia Commonwealth University) (submittedVersion, cc-by)
- Funders
- Georgia Clinical and Translational Science Alliance (KL2TR000057)
- National Institutes of Health (KL2TR000057)
- National Center for Advancing Translational Sciences
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- liver X receptor, microglial activation, nitric oxide synthase 2, experimental autoimmune encephalomyelitis, neuroinflammation, histone deacetylase, histone acetylation, NF-κB p50, transcriptional repression, GW3965, reverse cholesterol transport, lipopolysaccharide, interferon-gamma
- MeSH terms
- Liver X Receptors, Animals, Animals, Newborn, Benzoates, Benzylamines, Cells, Cultured, Deoxyribonucleases, Encephalomyelitis, Autoimmune, Experimental, Histones, Lipopolysaccharides, Mice, Inbred C57BL, Mice, Inbred ICR, Peptide Fragments, Protein Binding, Cytokines, Microglia, Gene Expression Profiling, RNA, Small Interfering, Chromatin Immunoprecipitation, Mice, Nitric Oxide Synthase Type II, Orphan Nuclear Receptors, Myelin-Oligodendrocyte Glycoprotein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Liver X receptor-dependent inhibition of microglial nitric oxide synthase 2. https://app.cochat.ai/papers/10.1186/s12974-015-0247-2
- The paper
- Secor McVoy, J. R., Oughli, H. A., & Oh, U. (2015). Liver X receptor-dependent inhibition of microglial nitric oxide synthase 2. Journal of Neuroinflammation. https://doi.org/10.1186/s12974-015-0247-2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.